183 related articles for article (PubMed ID: 1615481)
21. Properties of a recombinant bovine tissue factor expressed by Silkworm pupae and its performance as an Owren-type prothrombin time reagent for warfarin monitoring.
Okuda M; Taniguchi T; Takamiya O
Thromb Res; 2012 Sep; 130(3):520-7. PubMed ID: 22698434
[TBL] [Abstract][Full Text] [Related]
22. The dependence of the International Sensitivity Index on the coagulometer used to perform the prothrombin time.
Ray MJ; Smith IR
Thromb Haemost; 1990 Jun; 63(3):424-9. PubMed ID: 2402745
[TBL] [Abstract][Full Text] [Related]
23. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
van den Besselaar AM
J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
[TBL] [Abstract][Full Text] [Related]
24. The effect of some instruments for prothrombin time testing on the International Sensitivity Index (ISI) of two rabbit tissue thromboplastin reagents.
Poggio M; van den Besselaar AM; van der Velde EA; Bertina RM
Thromb Haemost; 1989 Nov; 62(3):868-74. PubMed ID: 2595661
[TBL] [Abstract][Full Text] [Related]
25. [Initial experiences with a recombinant human tissue thromboplastin in oral anticoagulation].
Vogt A; Woodhams B; Marbet GA
Schweiz Med Wochenschr; 1993 Jan; 123(3):74-6. PubMed ID: 8426950
[TBL] [Abstract][Full Text] [Related]
26. A comparison of seven prothrombin time reagents--development of an evaluation strategy.
Carter CJ; Griswold DJ; Louis RA; Hershler R; Wadsworth LD
Mod Pathol; 1988 Jul; 1(4):284-7. PubMed ID: 3237706
[TBL] [Abstract][Full Text] [Related]
27. [Control of oral anticoagulation. Current concepts].
Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
[TBL] [Abstract][Full Text] [Related]
28. Multi-center study of thromboplastin calibration precision--influence of reagent species, composition, and International Sensitivity Index (ISI).
van den Besselaar AM; Bertina RM
Thromb Haemost; 1993 Jan; 69(1):35-40. PubMed ID: 8446936
[TBL] [Abstract][Full Text] [Related]
29. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
Robert A; Chazouillères O
Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
[TBL] [Abstract][Full Text] [Related]
30. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
Loeliger EA; van den Besselaar AM; Lewis SM
Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
[TBL] [Abstract][Full Text] [Related]
31. Validity of the INR system for patients with liver impairment.
Denson KW; Reed SV; Haddon ME
Thromb Haemost; 1995 Jan; 73(1):162. PubMed ID: 7740488
[No Abstract] [Full Text] [Related]
32. Influence of three types of automated coagulometers on the international sensitivity index (ISI) of rabbit, human, and recombinant human tissue factor preparations--a multicenter study.
van den Besselaar AM; Houbouyan LL; Aillaud MF; Denson KW; Johnston M; Kitchen S; Lindahl TL; Marren M; Martinuzzo ME; Droullé C; Tripodi A; Vergnes C
Thromb Haemost; 1999 Jan; 81(1):66-70. PubMed ID: 9974377
[TBL] [Abstract][Full Text] [Related]
33. Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome.
Della Valle P; Crippa L; Garlando AM; Pattarini E; Safa O; Viganò D'Angelo S; D'Angelo A
Haematologica; 1999 Dec; 84(12):1065-74. PubMed ID: 10586206
[TBL] [Abstract][Full Text] [Related]
34. [Suggestions and propositions to resolve some issues for standardization of prothrombin time and activated partial thromboplastin time].
Kagawa K; Fukutake K
Rinsho Byori; 1999 May; 47(5):431-7. PubMed ID: 10375964
[TBL] [Abstract][Full Text] [Related]
35. A Multi-centre study to evaluate method dependency of the international sensitivity index of bovine thromboplastin.
Peters RH; van den Besselaar AM; Olthuis FM
Thromb Haemost; 1989 Apr; 61(2):166-9. PubMed ID: 2665170
[TBL] [Abstract][Full Text] [Related]
36. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
Gouin I; Horellou MH; Conard J; Samama M
Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
Adcock DM; Johnston M
Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
[TBL] [Abstract][Full Text] [Related]
38. [Introduction of international normalized ratio of prothrombin time to evaluate multiple depletions of coagulation factors].
Fujita S; Kagawa K; Fukutake K
Rinsho Byori; 2002 Jun; 50(6):618-24. PubMed ID: 12166083
[TBL] [Abstract][Full Text] [Related]
39. Sensitivity of commercial prothrombin time reagents to detect coagulation factor deficiencies in equine plasma.
Mischke R; Junker J; Deegen E
Vet J; 2006 Jan; 171(1):114-9. PubMed ID: 16427588
[TBL] [Abstract][Full Text] [Related]
40. [Methodological aspects of the photometric determination of prothrombin time using chromogenic substrates].
Dati F; Kolde HJ; Heimburger N; Keller F
J Clin Chem Clin Biochem; 1986 Nov; 24(11):877-88. PubMed ID: 3806016
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
